Interferon beta-lb in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial

The University of British Columbia MS/MRI Analysis Group, The IFNB Multiple Sclerosis Study Group

Research output: Contribution to journalArticlepeer-review

1168 Scopus citations

Fingerprint

Dive into the research topics of 'Interferon beta-lb in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences